Found: 9
Select item for more details and to access through your institution.
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor).
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 2, p. 441, doi. 10.1007/s13555-023-01075-y
- By:
- Publication type:
- Article
Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 11, p. 2911, doi. 10.1007/s13555-023-01015-w
- By:
- Publication type:
- Article
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 5, p. 2256, doi. 10.1007/s12325-022-02065-w
- By:
- Publication type:
- Article
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 727, doi. 10.1007/s13555-022-00690-5
- By:
- Publication type:
- Article
Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 1, p. 73, doi. 10.1007/s13555-019-00337-y
- By:
- Publication type:
- Article
Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 1, p. 73, doi. 10.1007/s13555-019-00337-y
- By:
- Publication type:
- Article
Basic Considerations for the Use of Monoclonal Antibodies in Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2018, v. 58, n. 10, p. 1689, doi. 10.1111/head.13439
- By:
- Publication type:
- Article